Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Eltrombopag for myelodysplastic syndromes or chronic myelomonocytic leukaemia with no excess blasts and thrombocytopenia: a French multicentre retrospective real-life study.
Comont T, Meunier M, Cherait A, Santana C, Cluzeau T, Slama B, Laribi K, Giraud JT, Dimicoli S, Berceanu A, Le Clech L, Cony-Makhoul P, Gruson B, Torregrosa J, Sanhes L, Jachiet V, Azerad MA, Al Jijakli A, Gyan E, Gaudin C, Broner J, Guerveno C, Guillaume T, Ades PL, Beyne-Rauzy O, Fenaux P; Groupe Francophone des Myélodysplasies (GFM). Comont T, et al. Among authors: guerveno c. Br J Haematol. 2021 Jul;194(2):336-343. doi: 10.1111/bjh.17539. Epub 2021 Jun 20. Br J Haematol. 2021. PMID: 34151423 Free article.
Clinical characteristics, management and outcome of COVID-19-associated immune thrombocytopenia: a French multicentre series.
Mahévas M, Moulis G, Andres E, Riviere E, Garzaro M, Crickx E, Guillotin V, Malphettes M, Galicier L, Noel N, Darnige L, Terriou L, Guerveno C, Sanchis-Borja M, Moulinet T, Meunier B, Ebbo M, Michel M, Godeau B. Mahévas M, et al. Among authors: guerveno c. Br J Haematol. 2020 Aug;190(4):e224-e229. doi: 10.1111/bjh.17024. Epub 2020 Aug 4. Br J Haematol. 2020. PMID: 32678953 Free PMC article. Clinical Trial. No abstract available.
[Refractory cutaneous leishmaniasis: Benefit of miltefosine].
Guerveno C, Delavigne K, Berry A, Martin-Blondel G, Delobel P. Guerveno C, et al. Med Mal Infect. 2019 Jun;49(4):281-283. doi: 10.1016/j.medmal.2018.11.009. Epub 2018 Dec 13. Med Mal Infect. 2019. PMID: 30554949 French. No abstract available.